RESUMEN
Brain gene expression profiling studies of suicide and depression using oligonucleotide microarrays have often failed to distinguish these two phenotypes. Moreover, next generation sequencing approaches are more accurate in quantifying gene expression and can detect alternative splicing. Using RNA-seq, we examined whole-exome gene and exon expression in non-psychiatric controls (CON, N=29), DSM-IV major depressive disorder suicides (MDD-S, N=21) and MDD non-suicides (MDD, N=9) in the dorsal lateral prefrontal cortex (Brodmann Area 9) of sudden death medication-free individuals post mortem. Using small RNA-seq, we also examined miRNA expression (nine samples per group). DeSeq2 identified 35 genes differentially expressed between groups and surviving adjustment for false discovery rate (adjusted P<0.1). In depression, altered genes include humanin-like-8 (MTRNRL8), interleukin-8 (IL8), and serpin peptidase inhibitor, clade H (SERPINH1) and chemokine ligand 4 (CCL4), while exploratory gene ontology (GO) analyses revealed lower expression of immune-related pathways such as chemokine receptor activity, chemotaxis and cytokine biosynthesis, and angiogenesis and vascular development in (adjusted P<0.1). Hypothesis-driven GO analysis suggests lower expression of genes involved in oligodendrocyte differentiation, regulation of glutamatergic neurotransmission, and oxytocin receptor expression in both suicide and depression, and provisional evidence for altered DNA-dependent ATPase expression in suicide only. DEXSEq analysis identified differential exon usage in ATPase, class II, type 9B (adjusted P<0.1) in depression. Differences in miRNA expression or structural gene variants were not detected. Results lend further support for models in which deficits in microglial, endothelial (blood-brain barrier), ATPase activity and astrocytic cell functions contribute to MDD and suicide, and identify putative pathways and mechanisms for further study in these disorders.
Asunto(s)
Adenosina Trifosfatasas/metabolismo , Encéfalo/fisiopatología , Trastorno Depresivo Mayor/fisiopatología , Células Endoteliales/fisiología , Exones , Neuroglía/fisiología , Suicidio , Adulto , Anciano , Encéfalo/enzimología , Encéfalo/metabolismo , Estudios de Casos y Controles , Trastorno Depresivo Mayor/genética , Trastorno Depresivo Mayor/metabolismo , Trastorno Depresivo Mayor/psicología , Células Endoteliales/enzimología , Células Endoteliales/metabolismo , Femenino , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Humanos , Masculino , MicroARNs/metabolismo , Persona de Mediana Edad , Neuroglía/enzimología , Neuroglía/metabolismo , Corteza Prefrontal/enzimología , Corteza Prefrontal/metabolismo , Corteza Prefrontal/fisiopatología , ARN Mensajero/metabolismo , Análisis de Secuencia de ARN/métodos , Transcriptoma , Ácido gamma-Aminobutírico/metabolismoRESUMEN
Brain region-specific abnormalities in serotonergic transmission appear to underlie suicidal behavior. Alterations of RNA editing on the serotonin receptor 2C (HTR2C) pre-mRNA in the brain of suicides produce transcripts that attenuate 5-HT2CR signaling by impairing intracellular G-protein coupling and subsequent intracellular signal transduction. In brain, the distribution of RNA-editing enzymes catalyzing deamination (A-to-I modification) shows regional variation, including within the cerebral cortex. We tested the hypothesis that altered pre-mRNA 5-HT2CR receptor editing in suicide is region-specific. To this end, we investigated the complete 5-HT2CR mRNA-editing profile in two architectonically distinct cortical areas involved in mood regulation and decision-making in a clinically well-characterized cohort of age- and sex-matched non-psychiatric drug-free controls and depressed suicides. By using an original biochemical detection method, that is, capillary electrophoresis single-stranded conformational polymorphism (CE-SSCP), we corroborated the 5-HT2CR mRNA-editing profile previously described in the dorsolateral prefrontal cortex (Brodmann area 9 (BA9)). Editing of 5-HT2CR mRNA displayed clear regional difference when comparing dorsolateral prefrontal cortex (BA9) and anterior cingulate cortex (BA24). Compared with non-psychiatric control individuals, alterations of editing levels of 5-HT2CR mRNA were detected in both cortical areas of depressed suicides. A marked increase in editing on 5-HT2CR was especially observed in the anterior cingulate cortex in suicides, implicating this cortical area in suicide risk. The results suggest that region-specific changes in RNA editing of 5-HT2CR mRNA and deficient receptor function likely contribute to the etiology of major depressive disorder or suicide.
Asunto(s)
Trastorno Depresivo Mayor/genética , Giro del Cíngulo/metabolismo , Corteza Prefrontal/metabolismo , Edición de ARN/genética , ARN Mensajero/metabolismo , Receptor de Serotonina 5-HT2C/genética , Conducta Autodestructiva/genética , Suicidio , Adolescente , Adulto , Autopsia , Estudios de Casos y Controles , Corteza Cerebral/metabolismo , Desaminación/genética , Electroforesis Capilar , Femenino , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo Conformacional Retorcido-Simple , Adulto JovenRESUMEN
The G/C single-nucleotide polymorphism in the serotonin 1a receptor promoter, rs6295, has previously been linked with depression, suicide and antidepressant responsiveness. In vitro studies suggest that rs6295 may have functional effects on the expression of the serotonin 1a receptor gene (HTR1A) through altered binding of a number of transcription factors. To further explore the relationship between rs6295, mental illness and gene expression, we performed dual epidemiological and biological studies. First, we genotyped a cohort of 1412 individuals, randomly split into discovery and replication cohorts, to examine the relationship between rs6295 and five psychiatric outcomes: history of psychiatric hospitalization, history of suicide attempts, history of substance or alcohol abuse, current posttraumatic stress disorder (PTSD), current depression. We found that the rs6295G allele is associated with increased risk for substance abuse, psychiatric hospitalization and suicide attempts. Overall, exposure to either childhood or non-childhood trauma resulted in increased risk for all psychiatric outcomes, but we did not observe a significant interaction between rs6295 and trauma in modulating psychiatric outcomes. In conjunction, we also investigated the potential impact of rs6295 on HTR1A expression in postmortem human brain tissue using relative allelic expression assays. We found more mRNA produced from the C versus the G-allele of rs6295 in the prefrontal cortex (PFC), but not in the midbrain of nonpsychiatric control subjects. Further, in the fetal cortex, rs6295C allele exhibited increased relative expression as early as gestational week 18 in humans. Finally, we found that the C:G allelic expression ratio was significantly neutralized in the PFC of subjects with major depressive disorder (MDD) who committed suicide as compared with controls, indicating that normal patterns of transcription may be disrupted in MDD/suicide. These data provide a putative biological mechanism underlying the association between rs6295, trauma and mental illness. Moreover, our results suggest that rs6295 may affect transcription during both gestational development and adulthood in a region-specific manner, acting as a risk factor for psychiatric illness. These findings provide a critical framework for conceptualizing the effects of a common functional genetic variant, trauma exposure and their impact on mental health.
Asunto(s)
Trastornos Mentales/genética , Receptor de Serotonina 5-HT1A/genética , Factores de Transcripción/genética , Adolescente , Adulto , Anciano , Encéfalo/metabolismo , Femenino , Expresión Génica/genética , Predisposición Genética a la Enfermedad/genética , Humanos , Masculino , Trastornos Mentales/metabolismo , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple/genética , Receptor de Serotonina 5-HT1A/metabolismo , Adulto JovenRESUMEN
OBJETIVO: determinar los efectos de un programa de ocho semanas de entrenamiento en superficies inestables con y sin trabajo de fuerza, sobre el equilibrio y la capacidad funcional en adultos mayores de 60 años, pertenecientes al programa "Escuelas populares del deporte" del INDER Medellín. METODOLOGIA: se llevó a cabo un estudio experimental simple, ciego y enmascarado con asignación al azar de 34 sujetos a dos grupos de intervención con y sin trabajo de fuerza sobre superficies inestables; se midió el equilibrio unipodal, bipodal con ojos abiertos y cerrados, además de pruebas funcionales como Up and Go, arm curl y chair test. RESULTADOS:las intervenciones con y sin trabajo de fuerza mejoraron el equilibrio total en 57,0 y 69,5 segundos respectivamente, sin diferencias estadísticamente significativas en la comparación entre los grupos (p= 0,13). Se mejoró la velocidad de la marcha con ambas intervenciones sin diferencias intragrupos estadísticamente significativas (p= 0,33) pero importantes para la práctica. CONCLUSION: ambas intervenciones mejoran el equilibrio, sin embargo existen diferencias importantes para la práctica a favor del programa sobre superficies inestables sin trabajo de fuerza, pues la intervención tiene un mejor efecto sobre el equilibrio unipodal y bipodal tanto con ojos abiertos como con cerrados.
OBJECTIVE:to determine the effects of an eight-week training program on unstable surfaces with and without strength work regarding balance and functional capacity in adults over 60 who belong to the inder sport schools program in Medellín. METHODOLOGY: simple single-blind and masked experimental trials were conducted on 34 subjects who were randomly assigned to two intervention groups with and without strength work on unstable surfaces. Unipodal and bipodal balance was measured while the subjects' eyes were open and closed. In addition, functional tests such as Up and Go, Arm Curl and Chair Test were conducted. RESULTS : interventions with and without strength work improved total balance in 57.0 and 69.5 seconds respectively. The differences between the groups were not statistically significant (p = 0.33), nonetheless they were important. CONCLUSION: both interventions improve balance, however there are differences that are important in practice. These differences favor the program involving unstable surfaces without an unstable without strength work because the intervention has a better effect on unipodal and bipodal balance both with open and closed eyes.
RESUMEN
Anorexia nervosa (AN), bulimia nervosa (BN) and obsessive-compulsive disorder (OCD) are complex psychiatric disorders with shared obsessive features, thought to arise from the interaction of multiple genes of small effect with environmental factors. Potential candidate genes for AN, BN and OCD have been identified through clinical association and neuroimaging studies; however, recent genome-wide association studies of eating disorders (ED) so far have failed to report significant findings. In addition, few, if any, studies have interrogated postmortem brain tissue for evidence of expression quantitative trait loci (eQTLs) associated with candidate genes, which has particular promise as an approach to elucidating molecular mechanisms of association. We therefore selected single-nucleotide polymorphisms (SNPs) based on candidate gene studies for AN, BN and OCD from the literature, and examined the association of these SNPs with gene expression across the lifespan in prefrontal cortex of a nonpsychiatric control cohort (N=268). Several risk-predisposing SNPs were significantly associated with gene expression among control subjects. We then measured gene expression in the prefrontal cortex of cases previously diagnosed with obsessive psychiatric disorders, for example, ED (N=15) and OCD/obsessive-compulsive personality disorder or tics (OCD/OCPD/Tic; N=16), and nonpsychiatric controls (N=102) and identified 6 and 286 genes that were differentially expressed between ED compared with controls and OCD cases compared with controls, respectively (false discovery rate (FDR) <5%). However, none of the clinical risk SNPs were among the eQTLs and none were significantly associated with gene expression within the broad obsessive cohort, suggesting larger sample sizes or other brain regions may be required to identify candidate molecular mechanisms of clinical association in postmortem brain data sets.
Asunto(s)
Anorexia Nerviosa/genética , Anorexia Nerviosa/patología , Bulimia Nerviosa/genética , Bulimia Nerviosa/patología , Trastorno Obsesivo Compulsivo/genética , Trastorno Obsesivo Compulsivo/patología , Polimorfismo de Nucleótido Simple/genética , Trastornos de Tic/genética , Trastornos de Tic/patología , Adolescente , Adulto , Estudios de Cohortes , Femenino , Regulación de la Expresión Génica/genética , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad/genética , Humanos , Masculino , Persona de Mediana Edad , Corteza Prefrontal/patología , Sitios de Carácter Cuantitativo/genética , Valores de Referencia , Adulto JovenRESUMEN
En el campo de la salud humana, el desarrollo, validación y uso de biomarcadores como herramientas de información para la evaluación de factores de riesgos asociados a la exposición a agentes ambientales, se incrementa cada día por la necesidad de conocer acerca de los efectos adversos generados por los diferentes entornos laborales y estilos de vida. Un biomarcador es un evento que se produce en un sistema biológico y se interpreta como indicador del estado de salud, de la esperanza de vida o del riesgo de enfermedad. Suelen clasificarse en biomarcadores de: exposición, efecto y de susceptibilidad. En esta revisión se plantea su importancia en la compresión de diferentes aspectos de las enfermedades como: diagnóstico, tratamiento, prevención, progresión de la enfermedad, respuestas a la terapia, así como su aplicación en la evaluación experimental toxicológica para el desarrollo de medicamentos o pesticidas. Además de su contribución en el desarrollo de diferentes campos de estudio como: la toxicología, salud ocupacional y la carcinogénesis.
In the field of human health, the development, validation, and use of biomarkers as information tools to assess risk factors associated with exposure to environmental agents increases daily. This is a result of the need to understand the adverse effects of the various work environments and lifestyles. A biomarker is an event that takes place in a biological system and is understood as an indicator of health status, life expectancy, or disease risk. Biomarkers usually fall within the following categories: exposure, effect, and susceptibility biomarkers. This review will discuss their importance in understanding different aspects of diseases such as diagnosis, treatment, prevention, disease progression, response to therapy, and their application in toxicological experimental evaluation for the development of drugs or pesticides. Furthermore, their contribution to the development of different fields of study such as toxicology, occupational health, and carcinogenesis shall also be discussed.
Asunto(s)
Humanos , Toxicología , Biomarcadores , Salud Laboral , Riesgos Ambientales , CarcinogénesisRESUMEN
Anatomical evidence of brain damage from electroconvulsive therapy (ECT) is lacking; but there are no modern stereological studies in primates documenting its safety. Magnetic seizure therapy (MST) is under development as a less invasive form of convulsive therapy, and there is only one prior report on its anatomical effects. We discerned no histological lesions in the brains of higher mammals subjected to electroconvulsive shock (ECS) or MST, under conditions that model closely those used in humans. We sought to extend these findings by determining whether these interventions affected the number of neurons or glia in the frontal cortex or hippocampus. Twenty-four animals received 6 weeks of ECS, MST, or anesthesia alone, 4 days per week. After perfusion fixation, numbers of neurons and glia in frontal cortex and hippocampus were determined by unbiased stereological methods. We found no effect of either intervention on volumes or total number or numerical density of neurons or glia in hippocampus, frontal cortex, or subregions of these structures. Induction of seizures in a rigorous model of human ECT and MST therapy does not cause a change in the number of neurons or glia in potentially vulnerable regions of brain. This study, while limited to young, healthy, adult subjects, provides further evidence that ECT and MST, when appropriately applied, do not cause structural damage to the brain.
Asunto(s)
Terapia Electroconvulsiva/efectos adversos , Magnetoterapia/efectos adversos , Neuroglía/patología , Neuronas/patología , Animales , Recuento de Células , Femenino , Lóbulo Frontal/patología , Hipocampo/patología , Macaca mulatta , MasculinoRESUMEN
Deficient levels of serotonin are associated with suicide and depression. Paradoxically, in the dorsal raphe nucleus (DRN) there are more serotonin neurons and more neuronal tryptophan hydroxylase-2 (TPH2) expression postmortem in depressed suicides. In this study, we sought to determine whether greater TPH2 expression in depressed suicides was the result of more TPH2 expression per neuron. In situ hybridization and computer-assisted image analysis were performed on tissue sections throughout the extent of the raphe nuclei at the level of silver grains per neuron to systematically quantify TPH2 neuronal expression. Depressed suicides have 26.5% more TPH2 grain density per neuron in the DRN compared with matched controls (P=0.04). The difference in grain density is greater at mid- and caudal anatomical levels across the rostrocaudal axis of the DRN. Densitometric analysis of TPH2 expression in the DRN subnuclei showed that higher expression levels were observed at posterior anatomical levels of depressed suicides (121% of control in the caudal subnucleus). Higher TPH2 expression in depressed suicides may explain more TPH2 protein and reflect a homeostatic response to deficient serotonin levels in the brains of depressed suicides. Localized changes in TPH2 expression in specific subnuclei of the DRN suggest that the serotonergic compensatory mechanism in depression and suicide is specifically regulated within the DRN and has implications for regions innervated by this subnucleus.
Asunto(s)
Trastorno Depresivo/enzimología , Proteínas del Tejido Nervioso/fisiología , Neuronas/química , ARN Mensajero/biosíntesis , Núcleos del Rafe/química , Suicidio , Triptófano Hidroxilasa/fisiología , Adulto , Vías Aferentes/fisiología , Anciano , Estudios de Casos y Controles , Muerte Súbita , Trastorno Depresivo/genética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteínas del Tejido Nervioso/biosíntesis , Proteínas del Tejido Nervioso/genética , Neuronas/enzimología , Corteza Prefrontal/fisiopatología , ARN Mensajero/análisis , Núcleos del Rafe/enzimología , Núcleos del Rafe/patología , Serotonina/fisiología , Suicidio/psicología , Triptófano Hidroxilasa/biosíntesis , Triptófano Hidroxilasa/genéticaRESUMEN
Impaired brain serotonin neurotransmission is a potential component of the diathesis of major depression. Tryptophan hydroxylase-2 (TPH2), is the rate limiting biosynthetic isoenzyme for serotonin that is preferentially expressed in the brain and a cause of impaired serotonin transmission. Here, we identify a novel TPH2 short isoform with truncated catalytic domain expressed in human brainstem, prefrontal cortex, hippocampus and amygdala. An exploratory study of 166 Caucasian subjects revealed association with major depression or suicide of a novel single nucleotide polymorphism (SNP) g.22879A>G located in exon 6 of this short isoform. This SNP and additional SNPs were discovered through a systematic characterization of the genetic architecture of the TPH2 gene for further genetic and functional investigations of its relationship to major depression and other psychopathology.
Asunto(s)
Encéfalo/enzimología , Trastorno Depresivo Mayor/genética , Polimorfismo de Nucleótido Simple , Triptófano Hidroxilasa/genética , Adenina , Mapeo Cromosómico , Trastorno Depresivo Mayor/enzimología , Guanina , Humanos , Isoenzimas/genética , Neuronas/enzimología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Población BlancaRESUMEN
Endogenous and exogenous cannabinoids (CBs) acting through the CB(1) receptors have been implicated in the regulation of several behavioral and neuroendocrine functions. Modulation of endocannabinoidergic system by ethanol in mouse brain, and the association of suicide and mood disorders with alcoholism suggest possible involvement of the cannabinoidergic system in the pathophysiology of depression and suicide. Therefore, the present study was undertaken to examine the levels of CB(1) receptors and mediated signaling in the dorsolateral prefrontal cortex (DLPFC) of subjects with major depression who had died by suicides (depressed suicides, DS). [(3)H]CP-55,940 and CB(1) receptor-stimulated [(35)S]GTPgammaS binding sites were analyzed in membranes obtained from DLPFC of DS (10) and matched normal controls (10). Upregulation (24%, P<0.0001) of CB(1) receptor density (B(max)) was observed in DS (644.6+/-48.8 fmol/mg protein) compared with matched controls (493.3+/-52.7 fmol/mg protein). However, there was no significant alteration in the affinity of receptor (DS; 1.14+/-0.08 vs control; 1.12+/-0.10 nM). Higher density of CB(1) receptors in DS (38%, P<0.001) was also demonstrated by Western blot analysis. The CB(1) receptor-stimulated [(35)S]GTPgammaS binding was significantly greater (45%, P<0.001) in the DLPFC of DS compared with matched controls. The observed upregulation of CB(1) receptors with concomitant increase in the CB(1) receptor-mediated [(35)S]GTPgammaS binding suggests a role for enhanced cannabinoidergic signaling in the prefrontal cortex of DS. The cannabinoidergic system may be a novel therapeutic target in the treatment of depression and/or suicidal behavior.
Asunto(s)
Trastorno Depresivo/metabolismo , Guanosina 5'-O-(3-Tiotrifosfato)/farmacología , Corteza Prefrontal/metabolismo , Receptor Cannabinoide CB1/metabolismo , Suicidio , Adolescente , Adulto , Anciano , Analgésicos/metabolismo , Analgésicos/farmacología , Ciclohexanoles/metabolismo , Ciclohexanoles/farmacología , Femenino , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Receptor Cannabinoide CB1/agonistas , Radioisótopos de Azufre , Tritio , Regulación hacia ArribaRESUMEN
Schizophrenia unfolds during the late period of brain maturation, while myelination is still continuing. In the present study, we used MRI and T2 relaxation analysis to measure the myelin water fraction in schizophrenia. In schizophrenia (n=30) compared with healthy subjects (n=27), overall white matter showed 12% lower myelin water fraction (P=0.031), with the most prominent effects on the left genu of the corpus callosum (36% lower, P=0.002). The left anterior genu was affected in both first-episode (P=0.035) and chronic patients (P=0.011). In healthy subjects, myelin water fraction in total white matter and in frontal white matter increased with age, and with years of education, indicating ongoing maturation. In patients with schizophrenia, neither relation was statistically significant. Post-mortem studies of anterior frontal cortex demonstrated less immunoreactivity of two oligodendrocyte-associated proteins in schizophrenia (2',3'-cyclic nucleotide 3'-phosphodiesterase by 33%, P=0.05; myelin-associated glycoprotein by 27%, P=0.14). Impaired myelination in schizophrenia could contribute to abnormalities of neural connectivity and persistent functional impairment in the illness.
Asunto(s)
Enfermedades Desmielinizantes/diagnóstico , Fibras Nerviosas Mielínicas/patología , Esquizofrenia/patología , 2',3'-Nucleótido Cíclico Fosfodiesterasas/análisis , Adulto , Composición Corporal/fisiología , Compartimentos de Líquidos Corporales/fisiología , Enfermedad Crónica , Enfermedades Desmielinizantes/complicaciones , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Análisis por Apareamiento , Persona de Mediana Edad , Vaina de Mielina/química , Glicoproteína Asociada a Mielina/análisis , Oligodendroglía/química , Oligodendroglía/patología , Valores de Referencia , Esquizofrenia/complicaciones , Agua/análisisRESUMEN
El objetivo de la investigación consistió en indagar sobre una eventual influencia del tratamiento ortodóncico en la imagen de cuerpo y en autoestima de los adolescentes. El universo de la muestra estuvo formado por los adolescentes que consultan en la Facultad de Odontología de la Universidad de Antioquia por su mala oclusión y por su problemática de cuerpo; de todos ellos se contó con la participación de nueve jóvenes que, voluntariamente, quisieron aportar a la investigacion con su relato personal. A los participantes se los entrevistó en dos oportunidades, teniendo en cuenta las siguientes categorías de análisis que orientaron el proceso investigativo: cuerpo-organismo, pedido-demanda y narcisismo-autoestima. Los hallazgos indicaron que el pedido que el adolescente hace a su ortodoncista, relacionado con algo concreto que afecta en su organismo físico -la mala oclusión-, generalmente le subyace una demanda sobre el cuerpo. Además, que el incremento en la autoestima, como resultado del tratamiento, si se logra, sólo se conquista de manera temporal.
Asunto(s)
Humanos , Masculino , Adolescente , Femenino , Imagen Corporal , Ortodoncia Correctiva , Psicología del Adolescente , Autoimagen , Colombia , Encuestas de Salud Bucal , Facultades de Odontología , Estética Dental , Maloclusión/diagnóstico , Maloclusión/epidemiología , Maloclusión/terapia , Narcisismo , Estudios de Evaluación como AsuntoRESUMEN
Recent imaging and postmortem studies suggest that impaired connectivity is involved in the pathophysiology of schizophrenia and major affective disorders. We investigated the presynaptic proteins complexin (Cx) I and Cx II in postmortem prefrontal cortex in schizophrenia (n = 13; six suicide, seven nonsuicide), major depression (n= 11, all suicide) and controls (n = 11) with an enzyme-linked immunoadsorbent assay (ELISA). Overall analysis indicated a significant difference between groups (F = 3.93, P = 0.007). Cx I (enriched in inhibitory terminals) was decreased 33% in schizophrenia (26% in schizophrenia/nonsuicide, 42% in schizophrenia/suicide) and 27% in major depression. Cx II (enriched in excitatory terminals) was not significantly different. Analysis of the ratio of Cx II/Cx I was carried out as an indication of the balance of excitatory to inhibitory terminals. A significant difference between groups (ANOVA, F = 6.42, P = 0.005) was observed. The mean value of Cx II/Cx I was significantly increased by 34% in schizophrenia (26% in schizophrenia/nonsuicide and 43% in schizophrenia/suicide) and by 32% in depression compared with control (Student-Newman-Keuls test, P = 0.05). Immunoreactivities of the two complexins were highly correlated in all groups. However, compared with controls and depression, samples from cases with schizophrenia appeared to have relatively less Cx I for similar amounts of Cx II. Immunocytochemical studies of rat frontal cortex after 3 weeks treatment with chlorpromazine, trifluoperazine or haloperidol revealed no differences in complexins, synaptophysin, SNAP-25, syntaxin or VAMP in comparison with animals treated with vehicle. Alterations of complexins may contribute to the molecular substrate for abnormalities of neural connectivity in severe mental disorders.
Asunto(s)
Trastorno Depresivo/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Corteza Prefrontal/metabolismo , Esquizofrenia/metabolismo , Proteínas Adaptadoras del Transporte Vesicular , Adulto , Anciano , Animales , Causas de Muerte , Trastorno Depresivo/mortalidad , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Ratas , Ratas Sprague-Dawley , Valores de Referencia , Análisis de Regresión , Esquizofrenia/mortalidad , SuicidioRESUMEN
Suicide and depression are associated with reduced serotonergic neurotransmission. In suicides, there is a reduction in serotonin transporter (SERT) sites and an increase in postsynaptic 5-HT(1A) receptors in localized regions of the prefrontal cortex. In depression, there is a diffuse decrease in SERT binding throughout the dorsoventral extent of the prefrontal cortex. Serotonergic innervation of the prefrontal cortex arises predominantly from neurons in the brainstem dorsal raphe nucleus (DRN). We, therefore, examined postmortem SERT binding and mRNA expression, as well as 5-HT(1A) autoreceptor binding in the DRN of 10 matched pairs of controls and depressed suicide victims. The concentration of SERT sites, SERT mRNA, and 5-HT(1A) binding was not different between controls and suicides (p >.05). In the DRN of suicides, the volume of tissue defined by 5-HT(1A) binding was 40% smaller than controls. An index of the total number of 5-HT(1A) receptors (receptor binding x volume of receptor distribution) was 43.3% lower in the DRN of suicides, compared with controls. The suicide group had 54% fewer DRN neurons expressing SERT mRNA compared with controls. In the serotonin neurons that expressed the SERT gene, expression per neuron was greater in suicides. Less total 5-HT(1A) and SERT binding is consistent with results of in vivo studies in depression. Less feedback inhibition of serotonin DRN firing via 5-HT(1A) autoreceptors and enhancement of serotonin action due to less uptake of serotonin, is consistent with compensatory changes in response to hypofunction in depressed suicides.
Asunto(s)
Tronco Encefálico/metabolismo , Proteínas Portadoras/metabolismo , Trastorno Depresivo/metabolismo , Glicoproteínas de Membrana/metabolismo , Proteínas de Transporte de Membrana , Proteínas del Tejido Nervioso , ARN Mensajero/biosíntesis , Receptores de Serotonina/metabolismo , Suicidio , 8-Hidroxi-2-(di-n-propilamino)tetralin/farmacología , Adulto , Anciano , Anciano de 80 o más Años , Autorradiografía , Proteínas Portadoras/biosíntesis , Femenino , Humanos , Concentración de Iones de Hidrógeno , Imipramina/análogos & derivados , Hibridación in Situ , Masculino , Glicoproteínas de Membrana/biosíntesis , Persona de Mediana Edad , Núcleos del Rafe/efectos de los fármacos , Núcleos del Rafe/metabolismo , Receptores de Serotonina 5-HT1 , Antagonistas de la Serotonina , Proteínas de Transporte de Serotonina en la Membrana Plasmática , Agonistas de Receptores de Serotonina/farmacología , Caracteres SexualesRESUMEN
Numerous abnormalities have been found in the serotonergic system in suicide attempters and completers. There is considerable evidence that the serotonergic system is partly under genetic control and that as yet unknown genetic factors mediate the risk for suicidal behavior independently of the genetic factors responsible for the heritability of major psychiatric conditions associated with suicide. An argument is made that there is a relationship of genetic variants to intermediate phenotypes, such as impulsivity, psychomotor change, pathological aggression and biological abnormalities including specific gene products. A variety of biological indices have been generated by new approaches using postmortem tissue and in vivo imaging that will provide a rich substrate for further genetic studies.
Asunto(s)
Química Encefálica/genética , Encéfalo/metabolismo , Depresión/genética , Proteínas de Transporte de Membrana , Proteínas del Tejido Nervioso , Receptores de Serotonina/genética , Serotonina/genética , Suicidio , Animales , Encéfalo/patología , Encéfalo/fisiopatología , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Depresión/metabolismo , Depresión/fisiopatología , Humanos , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Receptores de Serotonina/metabolismo , Serotonina/metabolismo , Proteínas de Transporte de Serotonina en la Membrana Plasmática , Triptófano Hidroxilasa/genética , Triptófano Hidroxilasa/metabolismoRESUMEN
Three polyketides alpha-pyrones, named passifloricins, were isolated from Passiflora foetida resin; their structures and relative configurations were assigned through 2D NMR spectroscopic analyses. These types of compounds were not detected in other passion flowers.
Asunto(s)
Pironas/aislamiento & purificación , Rosales/química , Espectroscopía de Resonancia Magnética , Hojas de la Planta/química , Pironas/químicaRESUMEN
Agonist activation of G protein-coupled receptors induces an increase in the binding of guanosine 5'-(gamma-[(35)S]thio)triphosphate ([(35)S]GTPgammaS); this increase in binding has been used as a tool to investigate receptor interaction with the heterotrimer guanine nucleotide-binding regulatory protein (G protein). The present study uses agonist-stimulated [(35)S]GTPgammaS binding to characterize serotonin 5-HT(2A/2C) receptors in rat brain membrane fractions and demonstrate the anatomical localization of the receptors by in vitro autoradiography on slide-mounted sections. The stimulatory effect of the agonist [1-(2,5-dimethoxy-4-iodophenyl)]-2 aminopropane (DOI) is compared to that of serotonin (5-HT). Autoradiography revealed a similar localization of DOI- and 5-HT-stimulated binding of [(35)S]GTPgammaS in distinct areas of prefrontal and parietal cortex, consistent with previously reported 5-HT(2A) receptor distribution. Specific binding was demonstrated in the frontal and parietal cortex, medial prefrontal, and cingular and orbital-insular areas as well as in the hippocampal formation, septal areas, the nucleus accumbens, and the choroid plexus. MDL 100105, a specific 5-HT(2A) antagonist, and ketanserin, an antagonist of 5-HT(2A/2C) receptors, blocked DOI stimulation in all labeled areas, whereas 5-HT stimulation was only partially blocked (70-80%). A small but significant inhibition was observed with the specific antagonist of 5-HT(2C/2B), SB 206553. This autoradiographic technique provides a useful tool for measuring in situ changes in specific receptor-Gq protein coupling in anatomically discrete brain regions, under physiological and pathological conditions.
Asunto(s)
Química Encefálica/fisiología , Proteínas de Unión al GTP/análisis , Proteínas de Unión al GTP/metabolismo , Guanosina 5'-O-(3-Tiotrifosfato)/farmacología , Receptores de Serotonina/metabolismo , Anfetaminas/farmacología , Animales , Autorradiografía/métodos , Relación Dosis-Respuesta a Droga , Fluorobencenos/farmacología , Subunidades alfa de la Proteína de Unión al GTP Gq-G11 , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Guanosina Difosfato/farmacología , Procesamiento de Imagen Asistido por Computador/métodos , Indoles/farmacología , Ketanserina/farmacología , Masculino , Proteínas de la Membrana/análisis , Proteínas de la Membrana/metabolismo , Piperidinas/farmacología , Piridinas/farmacología , Ensayo de Unión Radioligante/métodos , Ratas , Ratas Sprague-Dawley , Receptor de Serotonina 5-HT2A , Receptor de Serotonina 5-HT2C , Antagonistas de la Serotonina/farmacología , Agonistas de Receptores de Serotonina/farmacología , Fracciones Subcelulares/química , Fracciones Subcelulares/metabolismo , Radioisótopos de AzufreRESUMEN
BACKGROUND: Major depression and suicide are associated with fewer serotonin transporter (5-HTT) sites. The 5'-flanking promoter region of the 5-HTT gene has a biallelic insertion/deletion (5-HTTLPR). We assayed prefrontal cortical (PFC) 5-HTT binding in major depression and suicide and examine the relationship to the 5-HTTLPR allele. METHODS: Postmortem brain samples from 220 individuals were genotyped for the 5-HTTLPR polymorphism. Binding of 5-HTT was assayed by quantitative autoradiography in the PFC of a subset of subjects (n = 159). Clinical information, including DSM-III-R Axis I diagnoses, was obtained by psychological autopsy and medical chart review. RESULTS: Binding to 5-HTT was lower in the ventral PFC of suicides compared with nonsuicides and was lower throughout the PFC of subjects with a history of major depression. The 5-HTTLPR genotype was associated with major depression but not with suicide or 5-HTT binding. CONCLUSIONS: A diffuse reduction of 5-HTT binding in the PFC of individuals with major depression may reflect a widespread impairment of serotonergic function consistent with the range of psychopathologic features in major depression. The localized reduction in 5-HTT binding in the ventral PFC of suicides may reflect reduced serotonin input to that brain region, underlying the predisposition to act on suicidal thoughts. The 5-HTTLPR genotype was not related to the level of 5-HTT binding and does not explain why 5-HTT binding is lower in major depression or suicide. Arch Gen Psychiatry. 2000;57:729-738
Asunto(s)
Proteínas Portadoras/genética , Trastorno Depresivo/genética , Glicoproteínas de Membrana/genética , Proteínas de Transporte de Membrana , Proteínas del Tejido Nervioso , Polimorfismo Genético , Corteza Prefrontal/metabolismo , Regiones Promotoras Genéticas/genética , Serotonina/genética , Suicidio/estadística & datos numéricos , Adulto , Autorradiografía , Proteínas Portadoras/metabolismo , Trastorno Depresivo/diagnóstico , Trastorno Depresivo/psicología , Femenino , Expresión Génica , Genotipo , Humanos , Masculino , Glicoproteínas de Membrana/metabolismo , Trastornos Mentales/diagnóstico , Trastornos Mentales/genética , Persona de Mediana Edad , Serotonina/metabolismo , Proteínas de Transporte de Serotonina en la Membrana Plasmática , Factores Sexuales , Suicidio/psicologíaRESUMEN
Examination of brain regional neurochemistry in disease states reveals differences among brain regions. Knowing where alterations in brain function are located is crucial to understanding the disease effect. The anatomical distribution of neurotransmitter receptors is now often studied using quantitative autoradiography, but the large number of brain regions involved raises serious problems for statistical analysis of such data. Due to the dependence among the subjects in case control designs, statistical analysis based on a 'mixed model' is useful. Such an analysis is illustrated using a small autoradiographic data set. The Bonferroni method, the method of Holm, and two 'False Discovery Rate'-controlling methods for adjusting P-values for multiple comparisons are compared.